Literature DB >> 11893439

Interleukin-16 in tracheal aspirate fluids of newborn infants.

He Wang1, Julee Oei, Kei Lui, Richard Henry.   

Abstract

BACKGROUND: It is currently unknown if interleukin (IL)-16 exists in the lungs of ventilated infants, and because the predominant cells in the airways of infants with CLD are CD4+ macrophages, we hypothesized that IL-16 plays a role as a pro-inflammatory mediator in lung inflammation. AIMS: To examine if IL-16, a chemoattractant for CD4+ cells, is detectable in airway secretions of ventilated newborns. Its presence may be associated with lung inflammatory responses. STUDY
DESIGN: Cohort cross-sectional study.
SUBJECTS: Thirty-four mechanically ventilated newborn infants. MAIN OUTCOME MEASURES: Tracheal fluid (TF) specimens collected during the first month of life were examined for cell differentials determined from cytospin slides and supernatant was analyzed by ELISA for IL-16.
RESULTS: Eighty-three cross-sectional tracheal fluid (TF) specimens were analyzed. Eleven of the 27 preterm but none of the 7 term infants developed chronic lung disease (CLD). IL-16, ranging from 203 to 42,073 pg/ml, was detected in 16 of the 46 specimens obtained from CLD infants, 1 of the 30 specimens from 16 non-CLD preterm and 2 of the 7 specimens from 7 term infants (p<0.001). Leukocyte counts (median 16.6 vs. 2.0 x 10(-9)/l, p<0.0001) and percentage neutrophils (median 93% vs. 73%, p<0.001) were higher in IL-16 positive specimens.
CONCLUSION: IL-16 is detectable within the airway secretions of ventilated newborn infants and its presence is associated with a neutrophilic infiltration. Further studies are required to investigate its role in chronic inflammation in CLD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11893439     DOI: 10.1016/s0378-3782(01)00257-2

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

Review 1.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

2.  IκB kinase activity drives fetal lung macrophage maturation along a non-M1/M2 paradigm.

Authors:  Ashley N Stouch; Rinat Zaynagetdinov; Whitney J Barham; Amanda M Stinnett; James C Slaughter; Fiona E Yull; Hal M Hoffman; Timothy S Blackwell; Lawrence S Prince
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 3.  Intratracheal Clara cell secretory protein (CCSP) administration in preterm infants with or at risk of respiratory distress syndrome.

Authors:  Mohamed E Abdel-Latif; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2011-05-11

4.  Bronchial responsiveness is related to increased exhaled NO (FE(NO)) in non-smokers and decreased FE(NO) in smokers.

Authors:  Andrei Malinovschi; Christer Janson; Marieann Högman; Giovanni Rolla; Kjell Torén; Dan Norbäck; Anna-Carin Olin
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

5.  Pulmonary Biomarkers of Bronchopulmonary Dysplasia.

Authors:  Alecia Thompson; Vineet Bhandari
Journal:  Biomark Insights       Date:  2008-07-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.